search
Back to results

General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke (GASS)

Primary Purpose

Stroke

Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Etomidate
Succinylcholine
Propofol
Remifentanil
Lidocaine
Sponsored by
Rennes University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring ischemic stroke, thrombectomy, anesthesia, sedation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > 18 years
  • Body mass index < or equal to 35 kg/m² ,
  • Indication for thrombectomy, after multidisciplinary consultation,
  • Proximal artery occlusion in the anterior circulation (internal carotid artery, M1, M2,...), confirmed on imaging (angioscan or angio-MRI),
  • Written informed consent of the patient or a close / trusted person when possible, or emergency procedure,
  • Patient affiliated to or beneficiary of an health insurance

Non-inclusion Criteria:

  • Comorbidity committing short-term prognosis,
  • Hemodynamic instability,
  • Pregnant woman,
  • Contra-indication to sedation: pre-existing swallowing impairment; restless patient, not able to stay lying down; Glasgow score < 8,
  • Contra-indication to general anesthesia,
  • Intubated patient at inclusion,
  • Additional intracerebral hemorrhage,
  • Sign of occlusion in a different cerebral territory,
  • Known contra-indication to succinylcholine: hypersensitivity, hyperkaliemia,
  • Known contra-indication to one of the anesthesic agents,
  • Patient participating in another clinical trial, possibly interfering with the study procedures,
  • Patient in a known situation of deprivation of freedom, guardianship or curatorship.

Exclusion criteria:

  • Patients with deprivation of freedom will be excluded as soon as the investigator will have knowledge of the situation.

Sites / Locations

  • Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest
  • Service d'anesthésie-réanimation - Fondation A. de Rothschild
  • Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes
  • Service d'anesthésie-réanimation 1 - Hôpital Bretonneau, CHU de Tours

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

general anesthesia

sedation

Arm Description

General anesthesia with etomidate, succinylcholine, propofol and remifentanil

Sedation with remifentanil and local anesthesia with lidocaine

Outcomes

Primary Outcome Measures

Score on the modified Rankin scale

Secondary Outcome Measures

Recanalization delay
Delay between first symptoms and last angiography
Delay between patient's hospitalization and start of procedure
At the time of puncture
Quality of recanalization assessed with TICI (Thrombolysis in cerebral infarction) score
At the last angiography
NIHSS score
NIHSS score
Angiographic complications: number of patients wtih dissection, arterial rupture, thrombus in another territory
Mortality
Number of episodes of hypo- / hypertension
Number of patients with noradrenaline administration during anesthesia
Number of sedations converted to general anesthesia and reason

Full Information

First Posted
June 27, 2016
Last Updated
May 19, 2023
Sponsor
Rennes University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02822144
Brief Title
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
Acronym
GASS
Official Title
General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
September 29, 2016 (Actual)
Primary Completion Date
August 2020 (Actual)
Study Completion Date
August 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Rennes University Hospital

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In France, the annual incidence rate of acute ischaemic stroke is around 150 000 patients, 65 % of whom keep long-term disability. Several multicentric randomized controlled trials have shown the benefit of a mechanical thrombectomy in the acute phase of ischaemic stroke on functional disability, compared to a medical treatment alone (thrombolysis). The timeliness of revascularisation is an essential factor of good prognosis. This intra-arterial treatment, associated with thrombolysis if applicable, is the reference treatment of large-vessel occlusion. The stillness of the patient is required to control the safety of the recanalization. Currently, either a general anesthesia or a sedation can be performed. Several studies have shown a trend to superiority of the sedation but none was conducted with a high level of proof methodology. The aim of our multicentric randomized controlled trial is to compare sedation and general anesthesia during intra-arterial thrombectomy for an acute ischaemic stroke in the anterior cerebral circulation. The main outcome will be the efficacy on the functional neurological prognosis at 3 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
ischemic stroke, thrombectomy, anesthesia, sedation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
351 (Actual)

8. Arms, Groups, and Interventions

Arm Title
general anesthesia
Arm Type
Experimental
Arm Description
General anesthesia with etomidate, succinylcholine, propofol and remifentanil
Arm Title
sedation
Arm Type
Experimental
Arm Description
Sedation with remifentanil and local anesthesia with lidocaine
Intervention Type
Drug
Intervention Name(s)
Etomidate
Intervention Type
Drug
Intervention Name(s)
Succinylcholine
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Type
Drug
Intervention Name(s)
Remifentanil
Intervention Type
Drug
Intervention Name(s)
Lidocaine
Primary Outcome Measure Information:
Title
Score on the modified Rankin scale
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Recanalization delay
Description
Delay between first symptoms and last angiography
Time Frame
Day 1
Title
Delay between patient's hospitalization and start of procedure
Description
At the time of puncture
Time Frame
Day 1
Title
Quality of recanalization assessed with TICI (Thrombolysis in cerebral infarction) score
Description
At the last angiography
Time Frame
Day 1
Title
NIHSS score
Time Frame
Day 1
Title
NIHSS score
Time Frame
Day 7
Title
Angiographic complications: number of patients wtih dissection, arterial rupture, thrombus in another territory
Time Frame
Day 1
Title
Mortality
Time Frame
3 months
Title
Number of episodes of hypo- / hypertension
Time Frame
24 hours after thrombectomy
Title
Number of patients with noradrenaline administration during anesthesia
Time Frame
Day 1
Title
Number of sedations converted to general anesthesia and reason
Time Frame
Day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years Body mass index < or equal to 35 kg/m² , Indication for thrombectomy, after multidisciplinary consultation, Proximal artery occlusion in the anterior circulation (internal carotid artery, M1, M2,...), confirmed on imaging (angioscan or angio-MRI), Written informed consent of the patient or a close / trusted person when possible, or emergency procedure, Patient affiliated to or beneficiary of an health insurance Non-inclusion Criteria: Comorbidity committing short-term prognosis, Hemodynamic instability, Pregnant woman, Contra-indication to sedation: pre-existing swallowing impairment; restless patient, not able to stay lying down; Glasgow score < 8, Contra-indication to general anesthesia, Intubated patient at inclusion, Additional intracerebral hemorrhage, Sign of occlusion in a different cerebral territory, Known contra-indication to succinylcholine: hypersensitivity, hyperkaliemia, Known contra-indication to one of the anesthesic agents, Patient participating in another clinical trial, possibly interfering with the study procedures, Patient in a known situation of deprivation of freedom, guardianship or curatorship. Exclusion criteria: Patients with deprivation of freedom will be excluded as soon as the investigator will have knowledge of the situation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Axelle MAURICE, MD
Organizational Affiliation
Rennes University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Département d'anesthésie-réanimation - Hôpital de la Cavale Blanche, CHU de Brest
City
Brest
ZIP/Postal Code
29609
Country
France
Facility Name
Service d'anesthésie-réanimation - Fondation A. de Rothschild
City
Paris
ZIP/Postal Code
75019
Country
France
Facility Name
Fédération d'anesthésie-réanimation - Hôpital Pontchaillou, CHU de Rennes
City
Rennes
ZIP/Postal Code
35033
Country
France
Facility Name
Service d'anesthésie-réanimation 1 - Hôpital Bretonneau, CHU de Tours
City
Tours
ZIP/Postal Code
37011
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35226737
Citation
Maurice A, Eugene F, Ronziere T, Devys JM, Taylor G, Subileau A, Huet O, Gherbi H, Laffon M, Esvan M, Laviolle B, Beloeil H; GASS (General Anesthesia versus Sedation for Acute Stroke Treatment) Study Group and the French Society of Anesthesiologists (SFAR) Research Network. General Anesthesia versus Sedation, Both with Hemodynamic Control, during Intraarterial Treatment for Stroke: The GASS Randomized Trial. Anesthesiology. 2022 Apr 1;136(4):567-576. doi: 10.1097/ALN.0000000000004142.
Results Reference
result
PubMed Identifier
35857365
Citation
Tosello R, Riera R, Tosello G, Clezar CN, Amorim JE, Vasconcelos V, Joao BB, Flumignan RL. Type of anaesthesia for acute ischaemic stroke endovascular treatment. Cochrane Database Syst Rev. 2022 Jul 20;7(7):CD013690. doi: 10.1002/14651858.CD013690.pub2.
Results Reference
derived
PubMed Identifier
31154292
Citation
Maurice A, Ferre JC, Ronziere T, Devys JM, Subileau A, Laffon M, Laviolle B, Beloeil H; SFAR research network. GASS Trial study protocol: a multicentre, single-blind, randomised clinical trial comparing general anaesthesia and sedation during intra-arterial treatment for stroke. BMJ Open. 2019 Jun 1;9(5):e024249. doi: 10.1136/bmjopen-2018-024249.
Results Reference
derived

Learn more about this trial

General Anesthesia Versus Sedation During Intra-arterial Treatment for Stroke

We'll reach out to this number within 24 hrs